コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 0 muA, 100-300 Hz, n = 172 IC locations in 3 rhesus monkeys).
2 8)F-AV1451 ((18)F-T807) in mice, rats, and a rhesus monkey.
3 ng and quantifying the I2BS, in vivo, in the rhesus monkey.
4 rimental autoimmune encephalomyelitis in the rhesus monkey.
5 eneration and cell death in the normal aging rhesus monkey.
6 ed 50%-75% homology with mouse and >90% with rhesus monkey.
7 petitive, low-dose intrarectal challenges in rhesus monkeys.
8 neutralization-resistant virus challenges in rhesus monkeys.
9 memory T cells characterized as TRM cells in rhesus monkeys.
10 s and key cellular and molecular features in rhesus monkeys.
11 ctorization of three novel adenoviruses from rhesus monkeys.
12 neutralization-resistant virus challenges in rhesus monkeys.
13 used as a vaccine against DENV2 infection in rhesus monkeys.
14 ) and the lateral prefrontal cortex (PFC) of rhesus monkeys.
15 CNS pathology in the rhMOG/CFA EAE model in rhesus monkeys.
16 mental autoimmune encephalomyelitis (EAE) in rhesus monkeys.
17 ral immune responses in colorectal mucosa in rhesus monkeys.
18 onsistent with recent anatomical findings in rhesus monkeys.
19 ones from 34 cortical injection locations in rhesus monkeys.
20 ct on spatial working memory performances in rhesus monkeys.
21 fluenced vestibulo-ocular reflex learning in rhesus monkeys.
22 , boosted the plasma levels of decitabine in rhesus monkeys.
23 y) exhibited promising in vivo properties in rhesus monkeys.
24 lcus body patch, defined by fMRI in the same rhesus monkeys.
25 ghteen PET studies were performed in 3 adult rhesus monkeys.
26 axis function of male and female prepubertal rhesus monkeys.
27 multiple cortical areas, in freely behaving rhesus monkeys.
28 n immunodeficiency virus (SIV) challenges in rhesus monkeys.
29 ot also decrease food-reinforced behavior in rhesus monkeys.
30 on of PCK1 and G6PC upon glucose infusion in rhesus monkeys.
31 nd multiscale imaging of synaptic markers in rhesus monkeys.
32 on of ChIs in the postcommissural putamen of rhesus monkeys.
33 ered intra-amniotically at ~80% gestation in rhesus monkeys.
34 before and after corpus callosum section in rhesus monkeys.
35 ollowing both acute and chronic treatment in rhesus monkeys.
36 disrupts activity-based sleep parameters in rhesus monkeys.
37 of spatial and object WM tasks in adolescent rhesus monkeys.
38 e initiated to determine the effect of CR in rhesus monkeys.
39 e recognition by SIV Env-specific NAbs in 16 rhesus monkeys.
40 ne responses to 5 different Ad vectors in 26 rhesus monkeys.
41 n immunodeficiency virus (SIV) challenges in rhesus monkeys.
42 liably prolonged renal allograft survival in rhesus monkeys.
43 lly injected into the striatum of four adult rhesus monkeys.
44 e pairs of sites in primary visual cortex of rhesus monkeys.
45 schedule of cocaine and food availability in rhesus monkeys.
46 platforms protect against ZIKV challenge in rhesus monkeys.
47 that of HIV-infected humans and SIV-infected rhesus monkeys.
48 Uganda following blood analyses of sentinel Rhesus monkeys.
49 ed with better working memory performance in rhesus monkeys.
50 ex (V1) and the middle temporal area (MT) in rhesus monkeys.
51 two endovascular ischemic models in sixteen rhesus monkeys.
55 Gibbons, which are flanked in evolution by rhesus monkeys (12-lipoxygenating ALOX15) and orangutans
57 This study examined the hypothalamus of 51 rhesus monkeys (23 male, 18 female, 6.5-31 years old) us
58 imaging of [(18)F]mefway was performed on 58 rhesus monkeys (33 l/l, 25 s-carriers) to examine the re
59 al associated with 30% CR initiated in adult rhesus monkeys (7-14 years) and a preliminary report wit
61 with peak concentration (SUVs of 1.5-1.8 in rhesus monkeys) achieved within 7 min after injection.
66 of bivalent HIV-1 mosaic antigens to protect rhesus monkeys against acquisition of infection followin
67 n of Ebola virus are able to protect 100% of rhesus monkeys against lethal challenge when treatment w
68 neutralizing antibodies (bNAbs) can protect rhesus monkeys against simian-human immunodeficiency vir
69 maging was conducted on 27 CR and 17 control rhesus monkeys aged 19-31 years from a longitudinal stud
72 periments were performed to compare, in five rhesus monkeys, amphetamine-induced DA release and [(11)
74 esis, we pharmacogenetically inactivated the rhesus monkey amygdala, a subcortical region with distri
77 type-specific channelrhodopsin expression in Rhesus monkeys and apply this technique to modulate dopa
80 suring responses of MSTd neurons in two male rhesus monkeys and by applying a recently-developed meth
81 irus family, was isolated from the stools of rhesus monkeys and can be cultivated in vitro in monkey
82 fully protective dose of the bNAb PGT121 to rhesus monkeys and challenged them intravaginally with S
83 reas, PFC, and ventral intraparietal area of rhesus monkeys and found that adjacent neurons represent
84 ults are consistent with the hypothesis that rhesus monkeys and humans share a common neural shape re
86 a brain-machine interface (BMI) paradigm in rhesus monkeys and novel statistical analyses of neural
87 form are altered with aging and menopause in rhesus monkeys and that these metrics may be coupled wit
88 infection (IAI) with Ureaplasma in pregnant rhesus monkeys and to explore concentration-response rel
89 sseminate following mucosal SIV infection of rhesus monkeys and trigger components of the inflammasom
90 s interrogated with sera from infected mice, rhesus monkeys, and humans and with glycan-binding prote
92 netic stimulation of cortical neurons within rhesus monkey arcuate sulcus, during the execution of a
93 mental studies involving pediatric patients, rhesus monkeys are an ideal laboratory animal model to i
94 cific monoclonal antibodies in SHIV-infected rhesus monkeys as well as an impact on host immune respo
95 ausally promotes social donation behavior in rhesus monkeys, as it does in more egalitarian and monog
97 ed the severity of myelin deficit lesions in rhesus monkey brain induced by experimental autoimmune e
98 rmal aging; in particular, in area 46 of the rhesus monkey brain, the strength of microcolumns was sh
101 ssfully prevents islet allograft survival in rhesus monkeys, but induction with alefacept provides no
102 ranslated across species, including diabetic rhesus monkeys, but manifested with concomitant cardiac
103 le Gag-specific cellular immune responses in rhesus monkeys, but these responses were transient and w
104 etal, cingulate, and insular cortices in the rhesus monkey by using high-resolution anterograde trace
107 observed in 5 of 5 SIV239Deltanef-immunized rhesus monkeys challenged at 5 weeks with SIV239, i.e.,
108 of plasma viraemia to undetectable levels in rhesus monkeys chronically infected with the pathogenic
111 hemokine levels following the vaccination of rhesus monkeys compared to the vaccinia virus-based vect
114 ta suggest that persistent EBOV infection in rhesus monkeys could serve as a model for persistent EBO
115 Similar transcriptional profiling in the rhesus monkey dentate gyrus across postnatal development
116 In particular, the inoculation of DTMUV into rhesus monkeys did not result in either viremia or appar
118 rtical (brainstem and cerebellar) neurons in rhesus monkeys during a vestibular heading discriminatio
119 nal and translational stimuli experienced by rhesus monkeys during natural (e.g., walking, grooming)
120 d rapidly after intrarectal SIV infection of rhesus monkeys, during the 'eclipse' phase, and before d
121 tional measurement of lymphocryptovirus, the rhesus monkey EBV, demonstrated elevated levels in the b
122 ere we show that productive SIV infection in rhesus monkey ECs, but not TPs, is markedly restricted t
130 Dynamic PET experiments were performed on 4 rhesus monkeys (female; age range, 9-13 y) using a small
131 fluid (CSF) and lymph nodes (LN) of infected rhesus monkeys for weeks after virus has been cleared fr
132 okine effects on striatal DA function, eight rhesus monkeys (four male, four female) were administere
140 rphisms associated with drusenoid lesions in rhesus monkeys in ARMS2 and HTRA1 were similar in freque
142 that of HIV-infected humans and SIV-infected rhesus monkeys, including gp120-focused responses and ra
143 lar and humoral immune responses in neonatal rhesus monkeys, including mucosal responses that remaine
144 were subsequently challenged with thirty 50% rhesus monkey infectious doses of SIVmac251 6 weeks afte
147 ioides posadasii contamination in commercial rhesus monkey kidney (RhMK) cells and the subsequent nat
149 e a high-resolution transcriptional atlas of rhesus monkey (Macaca mulatta) brain development that co
150 ntrolateral prefrontal cortex (VLPFC) of the rhesus monkey (Macaca mulatta) respond to and integrate
151 h resolution electron micrographs from aging rhesus monkey (Macaca mulatta), provided by Alan Peters
153 elationship between behavioral inhibition in rhesus monkeys (Macaca mulatta) and airway hyperresponsi
154 scharge in the oculomotor vermis of behaving rhesus monkeys (Macaca mulatta) and found neurons that i
155 tons are altered with aging and menopause in rhesus monkeys (Macaca mulatta) and that these metrics c
157 ssed this issue by investigating pathways in rhesus monkeys (Macaca mulatta) from the amygdala to pOF
159 test this hypothesis, we trained four female rhesus monkeys (Macaca mulatta) to perform a multiple-fi
163 ecorded single-unit activity in the VLPFC of rhesus monkeys (Macaca mulatta) while they produced voca
171 whether CD8(+) T lymphocytes from vaccinated rhesus monkeys mediate viral inhibition in vitro and whe
176 sing the simian immunodeficiency virus (SIV)/rhesus monkey model of HIV rectal infection, we investig
180 oxin synthase activity of 12-lipoxygenating (rhesus monkey, mouse, rat, pig, humIle418Ala) and 15-lip
182 PDM to reduce cocaine self-administration by rhesus monkeys (N=4) using a novel procedure that featur
185 se pathway-mediated processing of APP in the rhesus monkey (nonhuman primate; NHP) CNS is not underst
189 o examine the effects of amygdala lesions in rhesus monkeys on attentional capture by specific facial
190 e of a marmoset can compare unfavorably with rhesus monkey performance on conventional testing paradi
191 om groups of neurons in visual area V4 while rhesus monkeys performed a contrast discrimination task
195 affiliative interactions of 29 two-year-old rhesus monkeys, previously observed as yearlings, at the
196 immune responses of infant and adult lungs, rhesus monkey primary airway epithelial cell cultures we
201 a-amniotic inoculation of Ureaplasma parvum, rhesus monkeys received AZI (12.5 mg/kg every 12 hours i
202 ltered during in vivo adaptation in mice and rhesus monkeys, rendering the cagT4SS nonfunctional; how
203 pan and that caloric restriction in mice and rhesus monkeys results in attenuation of age-related met
207 Here we investigated whether recombinant rhesus monkey rhadinovirus (RRV) could be used as a vacc
209 pacity of recombinant, replication-competent rhesus monkey rhadinovirus (RRV), a persisting herpesvir
210 sistent viruses (Rev of SIV and ORF57 of the rhesus monkey rhadinovirus) are dependent on the nature
211 ma and milk, whereas humans and SIV-infected rhesus monkeys (RMs), Asian-origin nonnatural SIV hosts,
213 fected B cells and CD20(+) spleen cells from rhesus monkeys shows increased expression of genes encod
214 reaching behaviors of lemurs, tamarins, and rhesus monkeys similarly bear on the evolutionary origin
215 ted auditory brainstem responses (ABRs) from rhesus monkeys spanning in age from 10 to 35 years old,
217 ntigen-4 (CTLA4) expression by alloactivated rhesus monkey T cells in the presence of CTLA4 immunoglo
219 on of antiretroviral therapy in SIV-infected rhesus monkeys that began antiretroviral therapy during
221 ammatory responses in otherwise asymptomatic rhesus monkeys that had survived infection in the absenc
222 in vivo using the rectal challenge model in rhesus monkeys that HIV-1-infected lymphocytes can trans
224 nv sequence variations in SIVmac251-infected rhesus monkeys that resulted in viral escape from NAbs.
225 re, we examine the activity of MT neurons in rhesus monkeys that were trained to discriminate depth s
226 f revealed preference theory, we measured in rhesus monkeys the frequency of repeated choices between
227 ons of two specialized cortical areas in the rhesus monkey, the high-order lateral prefrontal cortex
229 on kinetics and competence in Vero-E6 cells (rhesus monkey), tissue tropism in cultures of ex-vivo hu
230 mal PET studies were performed in rats and a rhesus monkey to evaluate tracer pharmacokinetics in the
231 itis (EAE) models in the common marmoset and rhesus monkey to model the association of EBV and MS.
233 ministered at approximately 80% gestation in rhesus monkeys to cause chorioamnionitis and FIRS that i
234 and posterior orbitofrontal cortex (pOFC) in rhesus monkeys to compare their relationship with excita
235 properties of (11)C-BU99008 were assessed in rhesus monkeys to determine brain penetration, brain dis
236 er, (11)C-GR103545, and performed a study in rhesus monkeys to estimate the in vivo receptor concentr
238 nyl]-4-yl)cyclopropane-1-carboxylic acid) in rhesus monkeys to image LPA1 in the lung in vivo with PE
239 delivered to two separate groups of pregnant rhesus monkeys to induce MIA: 1) late first trimester MI
242 tions in the medial premotor cortex (MPC) of Rhesus monkeys to represent in a time-varying fashion th
244 r full agonists, midazolam and lorazepam, in rhesus monkeys trained to self-administer midazolam or c
245 l cortical layers and the caudate-putamen of rhesus monkeys, trained in a spatial-versus-object, rule
247 RIM5alpha PRYSPRY domain, the PRYSPRY of the rhesus monkey TRIM5alpha that potently restricts HIV inf
248 A1 by protons was reversed in both mouse and rhesus monkey TRPA1 by exchange of distinct residues wit
251 ere performed in partially pancreatectomized rhesus monkeys (two autologous and four allogenic) witho
252 between CoB and mTOR inhibition, we studied rhesus monkeys undergoing MHC-mismatched islet allotrans
254 in and plasma of mice and in the plasma of a rhesus monkey using high-performance liquid chromatograp
255 of blocking experiments were performed in 3 rhesus monkeys using (11)C-LY2795050 and (11)C-carfentan
256 micrographs from the fornix of young and old rhesus monkeys using a semi-automatic detection algorith
257 mouse and compared findings to those in the rhesus monkey (V1 and lateral prefrontal cortex [LPFC]).
258 V1, and the middle temporal area, MT) while rhesus monkeys viewed different visual stimuli in differ
259 al cortex and the middle temporal area while rhesus monkeys viewed different visual stimuli in differ
260 ly varying both eye and head positions while rhesus monkeys viewed optic flow stimuli depicting vario
261 RISPR/Cas9 application in a primate species (rhesus monkey), we selected the beta-hemoglobin gene (HB
264 their postsynaptic sites in the amygdala in rhesus monkeys, we found that the anterior cingulate cor
266 sections and validated in brain tissue from rhesus monkeys, we show that neuronal loss is inconsiste
267 diffusion tractography in healthy humans and rhesus monkeys, we show that, whereas the LMC structural
284 responses in milk, hormone-induced lactating rhesus monkeys were vaccinated with a transmitted/founde
285 dia and bradyarrhythmia were not observed in rhesus monkeys when intravenous infusion of MK-3682 was
286 inding was observed in self-block studies in rhesus monkeys, which do not natively express NFTs.
287 fects of fluoxetine administered to juvenile rhesus monkeys who, as young adults, were imaged with po
288 2 reduction to cocaine abuse, we imaged four rhesus monkeys with [(11)C]DTBZ positron emission tomogr
289 y demonstrated that vaccination of lactating rhesus monkeys with a DNA prime/vector boost strategy in
290 demonstrated that immunization of lactating rhesus monkeys with a modified vaccinia Ankara (MVA) pri
291 ated the developmental stage of peripubertal rhesus monkeys with a series of morphometric, hormonal,
294 ments with (11)C-LY2459989 were performed in rhesus monkeys with arterial input function measurement.
295 was injected into the cerebrospinal fluid of rhesus monkeys with chronic simian immunodeficiency viru
296 s in support of recognition memory we tested rhesus monkeys with prefrontal-inferotemporal (PFC-IT) c
297 utralization-resistant SIVsmE660 variants in rhesus monkeys with restrictive TRIM5alpha alleles.
298 ased on the intravaginal challenge of female rhesus monkeys with SHIV(SF162P3N) and sought to validat
299 achieve a high efficiency of gene editing in rhesus monkey zygotes, with no detected off-target effec
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。